Europe Veterinary Vaccines Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Type, By Technology, By Distribution Channel (Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies), By Country and Growth Forecast,

Europe Veterinary Vaccines Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Type, By Technology, By Distribution Channel (Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies), By Country and Growth Forecast, 2023 - 2029


The Europe Veterinary Vaccines Market would witness market growth of 5.3% CAGR during the forecast period (2023-2029).

The main reasons for the widespread acceptance of ruminants, especially cattle vaccinations, around the region are the rising outbreaks of cattle disease and the continuously growing livestock population. Animals are an essential source of food, protein, and other industrial goods like wool and leather. Equine influenza, foot & mouth disease, and rabies vaccinations are the three most frequently administered to animals. These vaccinations prevent the transmission of dangerous pathogens by imitating the body's naturally developed immunity.

The need for animal vaccines for the cattle population is rising due to growing concerns about food security and improved animal husbandry. In addition, livestock output has increased due to rising consumer demand for animal products. The demand for animal products is also rising due to a number of variables, including changes in food choices brought on through shifting lifestyles and population expansion, therefore such elements are contributing to the market's growth.

A zoonosis of growing clinical importance is the hantavirus illness. With more than 2800 cases reported, Germany's incidence peaked for the first time in 2012. These viruses can spread from small mammals to people. Clinically significant infections are brought on by two hantavirus species in Germany. Every two to three years, the Puumala virus, spread by bank voles, produces significant illness epidemics in Germany's southwest, west, and Bavarian forests. In addition, infections are brought on by the Dobrava-Belgrad virus, which striped field mice spread throughout the north and east of the nation. Thus, the demand is anticipated to rise in response to the rising prevalence of zoonotic diseases to prevent these illnesses from affecting the human population, supporting regional market expansion.

The Germany market dominated the Europe Veterinary Vaccines Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $755 million by 2029. The UK market is estimated to grow a CAGR of 4.4% during (2023 - 2029). Additionally, The France market would showcase a CAGR of 6.1% during (2023 - 2029).

Based on Route of Administration, the market is segmented into Injection Vaccines, Oral Vaccines and Intranasal/Spray Vaccines. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines, Aquaculture Vaccines and Others. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zoetis, Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Inc., Virbac, Ceva Santé Animale, Neogen Corporation, Intas Pharmaceuticals Ltd. and Laboratoire LCV.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration
  • Injection Vaccines
  • Oral Vaccines
  • Intranasal/Spray Vaccines
By Type
  • Livestock Vaccines
  • Porcine Vaccines
  • Companion Animal Vaccines
  • Poultry Vaccines
  • Aquaculture Vaccines
  • Others
By Technology
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health, Inc.
  • Virbac
  • Ceva Santé Animale
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Laboratoire LCV
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Veterinary Vaccines Market, by Route of Administration
1.4.2 Europe Veterinary Vaccines Market, by Type
1.4.3 Europe Veterinary Vaccines Market, by Technology
1.4.4 Europe Veterinary Vaccines Market, by Distribution Channel
1.4.5 Europe Veterinary Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jun – 2022, Dec) Leading Players
Chapter 4. Europe Veterinary Vaccines Market by Route of Administration
4.1 Europe Injection Vaccines Market by Country
4.2 Europe Oral Vaccines Market by Country
4.3 Europe Intranasal/Spray Vaccines Market by Country
Chapter 5. Europe Veterinary Vaccines Market by Type
5.1 Europe Livestock Vaccines Market by Country
5.2 Europe Porcine Vaccines Market by Country
5.3 Europe Companion Animal Vaccines Market by Country
5.4 Europe Poultry Vaccines Market by Country
5.5 Europe Aquaculture Vaccines Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Veterinary Vaccines Market by Technology
6.1 Europe Live Attenuated Vaccines Market by Country
6.2 Europe Inactivated Vaccines Market by Country
6.3 Europe Toxoid Vaccines Market by Country
6.4 Europe Recombinant Vaccines Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Veterinary Vaccines Market by Distribution Channel
7.1 Europe Veterinary Hospitals Market by Country
7.2 Europe Veterinary Clinics Market by Country
7.3 Europe Retail Pharmacies Market by Country
Chapter 8. Europe Veterinary Vaccines Market by Country
8.1 Germany Veterinary Vaccines Market
8.1.1 Germany Veterinary Vaccines Market by Route of Administration
8.1.2 Germany Veterinary Vaccines Market by Type
8.1.3 Germany Veterinary Vaccines Market by Technology
8.1.4 Germany Veterinary Vaccines Market by Distribution Channel
8.2 UK Veterinary Vaccines Market
8.2.1 UK Veterinary Vaccines Market by Route of Administration
8.2.2 UK Veterinary Vaccines Market by Type
8.2.3 UK Veterinary Vaccines Market by Technology
8.2.4 UK Veterinary Vaccines Market by Distribution Channel
8.3 France Veterinary Vaccines Market
8.3.1 France Veterinary Vaccines Market by Route of Administration
8.3.2 France Veterinary Vaccines Market by Type
8.3.3 France Veterinary Vaccines Market by Technology
8.3.4 France Veterinary Vaccines Market by Distribution Channel
8.4 Russia Veterinary Vaccines Market
8.4.1 Russia Veterinary Vaccines Market by Route of Administration
8.4.2 Russia Veterinary Vaccines Market by Type
8.4.3 Russia Veterinary Vaccines Market by Technology
8.4.4 Russia Veterinary Vaccines Market by Distribution Channel
8.5 Spain Veterinary Vaccines Market
8.5.1 Spain Veterinary Vaccines Market by Route of Administration
8.5.2 Spain Veterinary Vaccines Market by Type
8.5.3 Spain Veterinary Vaccines Market by Technology
8.5.4 Spain Veterinary Vaccines Market by Distribution Channel
8.6 Italy Veterinary Vaccines Market
8.6.1 Italy Veterinary Vaccines Market by Route of Administration
8.6.2 Italy Veterinary Vaccines Market by Type
8.6.3 Italy Veterinary Vaccines Market by Technology
8.6.4 Italy Veterinary Vaccines Market by Distribution Channel
8.7 Rest of Europe Veterinary Vaccines Market
8.7.1 Rest of Europe Veterinary Vaccines Market by Route of Administration
8.7.2 Rest of Europe Veterinary Vaccines Market by Type
8.7.3 Rest of Europe Veterinary Vaccines Market by Technology
8.7.4 Rest of Europe Veterinary Vaccines Market by Distribution Channel
Chapter 9. Company Profiles
9.1 Zoetis, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Acquisition and Mergers:
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Boehringer Ingelheim International Gmbh
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Elanco Animal Health, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 Virbac
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 Ceva Santé Animale
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Joint-Ventures:
9.6.2.2 Product Launches and Product Expansions:
9.6.2.3 Acquisition and Mergers:
9.7 Neogen Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisition and Mergers:
9.8 Intas Pharmaceutical Ltd.
9.8.1 Company Overview
9.9 Laboratoire LCV
9.9.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings